Doctor of Philosophy, Case Western Reserve University, 2010, Neurosciences
Degeneration of chronically demyelinated axons is the leading causative factor in the progression of symptoms experienced by patients with multiple sclerosis (MS), despite the fact that MS has defied classification as a primary neurodegenerative disease. While there are many potential causes of neuronal damage immediately following demyelination, it is within the context of chronic demyelination that the fundamental and intrinsic mechanisms of axonal function can, themselves, become detrimental to axonal integrity. In the wake of demyelination, extensive submembranous cytoskeletal derangement occurs, allowing the once-nodal voltage-gated sodium channels (NaV) to diffuse along the denuded length of the axon. The immediate impact on the axon is two-fold; first is a spatially unrestricted influx of sodium and an associated increase in axoplasmic sodium ([Na]i), second is abrogation of saltatory conduction, which relies on focal sodium influx. In response to a global increase in [Na]i, typically caused by an action potential, the sodium/potassium adenosine triphosphatase (Na/K ATPase), or the sodium pump, hydrolyzes ATP to power the active transport of three intracellular sodium ions for two extracellular potassium ions and, thereby, repolarization of the cell. The cell is driven into an energy debt, causing stress to mitochondria and, thereby, decreasing
ATP production. Without sufficient axonal ATP, the Na/K ATPase cannot transport ions across the axolemma. With the Na/K ATPases unable to transport additional sodium across the axolemma, [Na]i increases and the sodium/calcium exchanger (NCX) is driven to reverse its function and exchange intracellular sodium for extracellular calcium. An unchecked rise in axoplasmic calcium can lead to the induction of many deleterious calcium-dependent degradative pathways and the eventual degeneration of the demyelinated axon. In these studies, the “secondary neurodegeneration” of MS is explored; specifically, how the energetic prope (open full item for complete abstract)
Committee: Bruce Trapp Ph.D. (Advisor); Robert Miller Ph.D. (Committee Chair); Gary Landreth Ph.D. (Committee Member); Evan Deneris Ph.D. (Committee Member); Nancy Oleinick Ph.D. (Committee Member)
Subjects: Anatomy and Physiology; Biology; Biomedical Research; Neurology; Pharmaceuticals; Scientific Imaging